SLC7A5
SLC7A5, also known as LAT1, CD98, E16 and MPE16, is the small subunit of a heteromeric amino acid transporter belonging to the L-type amino acid transporter family. It enables transmembrane transport of carboxylic acids, thyroid hormone and xenobiotics. Browse Assay Genie's current range of SLC7A5 research reagents below, or read on for the biology behind the target.
SLC7A5 (solute carrier family 7 member 5) encodes the small subunit of an amino acid transport complex. It enables transmembrane transporter activity and is involved in carboxylic acid transport, thyroid hormone transport and xenobiotic transport. In the complex it partners with SLC3A2, and together they form the assembly described as the SLC3A2/SLC7A5 (LAT1) complex.
The protein belongs to the amino acid-polyamine-organocation (APC) superfamily and the L-type amino acid transporter (LAT) family (TC 2.A.3.8). UniProt records it at the apical cell membrane, the cell membrane and the lysosome membrane, while NCBI Gene describes it at the apical plasma membrane, cytosol and microvillus membrane. The SLC7A5 gene sits in the HGNC groups for CD molecules, solute carrier family 7, and microRNA protein coding host genes. Its previous name was solute carrier family 7 (amino acid transporter light chain, L system), member 5.
SLC7A5 has been linked to disease in several settings. In hepatitis C virus infection, the SLC3A2/SLC7A5 complex facilitates viral entry into host cells and increases L-leucine uptake-mediated mTORC1 signalling, contributing to HCV-mediated pathogenesis. The gene is implicated in cholangiocarcinoma, colon cancer, hepatocellular carcinoma and lung squamous cell carcinoma, and is a biomarker of esophagitis, gastrointestinal system cancers, malignant astrocytoma and respiratory system cancers.
SLC7A5 is the transporter subunit of an amino acid transport complex, making it a focus for studying carboxylic acid movement across membranes.
SLC7A5 is implicated in cholangiocarcinoma, colon cancer, hepatocellular carcinoma and lung squamous cell carcinoma, and is a biomarker in several tumour types.
The SLC3A2/SLC7A5 complex aids hepatitis C virus entry and raises L-leucine uptake-driven mTORC1 activation, linking transport to viral pathogenesis.
SLC7A5 is involved in thyroid hormone and xenobiotic transport, relevant to studies of how these molecules cross cell membranes.
SLC7A5 is the small subunit of an amino acid transport complex and enables transmembrane transporter activity. It is involved in carboxylic acid, thyroid hormone and xenobiotic transport. It acts with SLC3A2, and the complex also supports L-leucine uptake that feeds mTORC1 signalling.
SLC7A5 is also called LAT1, CD98, E16, D16S469E and MPE16. UniProt names the protein large neutral amino acids transporter small subunit 1. Its earlier HGNC name was solute carrier family 7 (amino acid transporter light chain, L system), member 5.
Mouse and rat both have a Slc7a5 ortholog. In humans, SLC7A5 is implicated in cholangiocarcinoma, colon cancer, hepatocellular carcinoma and lung squamous cell carcinoma, and its complex contributes to hepatitis C virus propagation. Check the datasheet of any product for its validated reactivity.
Other solute carrier family members, including amino acid and monocarboxylate transporters, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q01650; product specifications from Assay Genie datasheets.